These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 12506240)

  • 1. [Chemokine receptor expression of hepatitis B virus-specific CD8+ lymphocyte in chronic B viral infection].
    Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):363-70. PubMed ID: 12506240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].
    Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
    Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):139-48. PubMed ID: 12499799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B.
    Fisicaro P; Valdatta C; Massari M; Loggi E; Biasini E; Sacchelli L; Cavallo MC; Silini EM; Andreone P; Missale G; Ferrari C
    Gastroenterology; 2010 Feb; 138(2):682-93, 693.e1-4. PubMed ID: 19800335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
    Zerbini A; Pilli M; Boni C; Fisicaro P; Penna A; Di Vincenzo P; Giuberti T; Orlandini A; Raffa G; Pollicino T; Raimondo G; Ferrari C; Missale G
    Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B].
    Xu B; Zhang Z; Shi Y; Chen XY; Wang FS
    Zhonghua Yi Xue Za Zhi; 2009 May; 89(17):1158-61. PubMed ID: 19595077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.
    Peng G; Li S; Wu W; Tan X; Chen Y; Chen Z
    Mol Immunol; 2008 Feb; 45(4):963-70. PubMed ID: 17868872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of CCR5/CXCR3 expressing CD8+ cells in liver damage and viral control during persistent hepatitis C virus infection.
    Larrubia JR; Calvino M; Benito S; Sanz-de-Villalobos E; Perna C; Pérez-Hornedo J; González-Mateos F; García-Garzón S; Bienvenido A; Parra T
    J Hepatol; 2007 Nov; 47(5):632-41. PubMed ID: 17560677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HBV-specific CD8+ T cells for sustained HBeAg seroconversion after lamivudine therapy].
    Lee CK; Han KH; Suh JH; Cho YS; Won SY; Chon CY; Moon YM; Park IS
    Korean J Hepatol; 2005 Mar; 11(1):34-42. PubMed ID: 15788883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of intrahepatic HBV-specific cytotoxic T-cells during and after acute HBV infection in humans.
    Sprengers D; van der Molen RG; Kusters JG; De Man RA; Niesters HG; Schalm SW; Janssen HL
    J Hepatol; 2006 Aug; 45(2):182-9. PubMed ID: 16516331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection.
    Franzese O; Kennedy PT; Gehring AJ; Gotto J; Williams R; Maini MK; Bertoletti A
    J Virol; 2005 Mar; 79(6):3322-8. PubMed ID: 15731226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B.
    Lin CY; Tsai MC; Huang CT; Hsu CW; Tseng SC; Tsai IF; Chen YC; Yeh CT; Sheen IS; Chien RN
    J Viral Hepat; 2007 Jul; 14(7):503-11. PubMed ID: 17576392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.
    Fisicaro P; Valdatta C; Boni C; Massari M; Mori C; Zerbini A; Orlandini A; Sacchelli L; Missale G; Ferrari C
    Gut; 2009 Jul; 58(7):974-82. PubMed ID: 19201769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and function of NKG2D molecule on intrahepatic CD8+ T cells in chronic viral hepatitis.
    Kennedy PT; Gehring AJ; Nowbath A; Selden C; Quaglia A; Dhillon A; Dusheiko G; Bertoletti A
    J Viral Hepat; 2008 Dec; 15(12):901-9. PubMed ID: 19087227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma.
    Gehring AJ; Ho ZZ; Tan AT; Aung MO; Lee KH; Tan KC; Lim SG; Bertoletti A
    Gastroenterology; 2009 Aug; 137(2):682-90. PubMed ID: 19394336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B.
    Sprengers D; van der Molen RG; Kusters JG; Hansen B; Niesters HG; Schalm SW; Janssen HL
    J Med Virol; 2006 May; 78(5):561-8. PubMed ID: 16555293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of HBV-DNA fluctuations on virus-specific CD8+ T cells in HBeAg+ chronic hepatitis B patients treated with a steroid and lamivudine.
    Gotto J; Webster GJ; Brown D; Jenkins J; Dusheiko GM; Bertoletti A
    J Viral Hepat; 2006 Jun; 13(6):415-25. PubMed ID: 16842445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tracking the source of the hepatitis B virus-specific CD8 T cells during lamivudine treatment.
    Malacarne F; Webster GJ; Reignat S; Gotto J; Behboudi S; Burroughs AK; Dusheiko GM; Williams R; Bertoletti A
    J Infect Dis; 2003 Feb; 187(4):679-82. PubMed ID: 12599086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.
    Tang TJ; de Man RA; Kusters JG; Kwekkeboom J; Hop WC; van der Molen RG; Schalm SW; Janssen HL
    J Med Virol; 2004 Feb; 72(2):215-22. PubMed ID: 14695662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8(+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions.
    Phillips S; Chokshi S; Riva A; Evans A; Williams R; Naoumov NV
    J Immunol; 2010 Jan; 184(1):287-95. PubMed ID: 19949099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.